Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions-Reference-Cited by-同舟云学术

Safety, tolerability, and efficacy of LiRIS 400 mg in women with interstitial cystitis/bladder pain syndrome with or without Hunner lesions

Author:

Evans Robert¹^ORCID,Kohan Alfred²^ORCID,Moldwin Robert³^ORCID,Radecki Daniel⁴,Geib Till⁴,Peters Kenneth M.⁵⁶^ORCID

Affiliation:

1. Urology Wake Forest Baptist Hospital Winston‐Salem North Carolina USA

2. Bethpage Division Advanced Urology Centers of New York Bethpage New York USA

3. Urologic Infectious/Inflammatory Diseases The Arthur Smith Institute for Urology Lake Success New York USA

4. Specialty Development AbbVie Irvine California USA

5. Urology Oakland University William Beaumont School of Medicine Royal Oak Michigan USA

6. Urology Beaumont Health Royal Oak Michigan USA

Funder

Allergan

Publisher

Wiley

Subject

Urology,Clinical Neurology

Link

Reference25 articles.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献